168 related articles for article (PubMed ID: 2306752)
1. Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype.
Testa U; Care A; Montesoro E; Fossati C; Giannella G; Masciulli R; Fagioli M; Bulgarini D; Habetswallner D; Isacchi G
Cancer Immunol Immunother; 1990; 31(1):11-8. PubMed ID: 2306752
[TBL] [Abstract][Full Text] [Related]
2. Long-term culture growth of CD4-CD8- lymphocytes exhibiting elevated non-MHC-restricted cytotoxic activity.
Montesoro E; Bulgarini D; Carè A; Masciulli R; Giannella G; Mariani G; Samoggia P; Salvo G; Habetswallner D; Testa U
J Biol Regul Homeost Agents; 1991; 5(1):10-8. PubMed ID: 1715635
[TBL] [Abstract][Full Text] [Related]
3. Molecular studies on LAK cells.
Fagioli M; Carè A; Ciccone E; Moretta L; Moretta A; Testa U; Falini B; Grignani F; Peschle C; Pelicci PG
Ann Ist Super Sanita; 1990; 26(3-4):357-68. PubMed ID: 1982603
[TBL] [Abstract][Full Text] [Related]
4. Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.
Vollenweider I; Moser R; Groscurth P
Cancer Immunol Immunother; 1994 Nov; 39(5):305-12. PubMed ID: 7987862
[TBL] [Abstract][Full Text] [Related]
5. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
Ozdemir O; Ravindranath Y; Savaşan S
J Immunother; 2005; 28(1):44-52. PubMed ID: 15614044
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
Lowrey DM; Hameed A; Lichtenheld M; Podack ER
Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
[TBL] [Abstract][Full Text] [Related]
10. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET
Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of interleukin 1 beta gene expression by an antisense oligonucleotide: obligatory role of interleukin 1 in the generation of lymphokine-activated killer cells.
Fujiwara T; Grimm EA
Cancer Res; 1992 Sep; 52(18):4954-9. PubMed ID: 1387585
[TBL] [Abstract][Full Text] [Related]
12. Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.
Ochoa AC; Gromo G; Alter BJ; Sondel PM; Bach FH
J Immunol; 1987 Apr; 138(8):2728-33. PubMed ID: 2435804
[TBL] [Abstract][Full Text] [Related]
13. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
Roussel E; Gerrard JM; Greenberg AH
Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo.
Nakata M; Smyth MJ; Norihisa Y; Kawasaki A; Shinkai Y; Okumura K; Yagita H
J Exp Med; 1990 Dec; 172(6):1877-80. PubMed ID: 2124255
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.
Fuchshuber PR; Lotzová E; Pollock RE
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):51-9. PubMed ID: 1651770
[TBL] [Abstract][Full Text] [Related]
16. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets.
Smyth MJ; Norihisa Y; Gerard JR; Young HA; Ortaldo JR
Cell Immunol; 1991 Dec; 138(2):390-403. PubMed ID: 1834347
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
[TBL] [Abstract][Full Text] [Related]
18. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells.
Clement MV; Haddad P; Soulie A; Guillet J; Sasportes M
Nouv Rev Fr Hematol (1978); 1990; 32(5):349-52. PubMed ID: 2099410
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.
Chong AS; Staren ED; Scuderi P
Cancer Immunol Immunother; 1992; 35(5):335-41. PubMed ID: 1382856
[TBL] [Abstract][Full Text] [Related]
20. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
